Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS

• Status: Not yet recruiting
• Trial end date: 2021-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a research study to understand and determine the effectiveness of electronic cigarettes versus nicotine replacement therapy in adults who smoke and also live with HIV/AIDS in effort to reduce cigarette smoking.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NYU Langone Health
• Treatments: Ethanol; Nicotine

Criteria

Inclusion Criteria:

• Current Combustible Cigarette (CC) smokers (more than 5 packs in a lifetime; smokes 4 or more days/week),

• Smokes at least 10 cigarettes per day on days they smoke CC.

• Motivated to quit smoking (at least a 5 on a 10-point Likert scale).

• Must be able to provide consent

• Agree to be randomized and followed-up with,

• Reside in New York City

• Be willing to use an e-cigarette or NRT for 12 weeks.

Exclusion Criteria:

• Are pregnant (as determined by urine test) or breastfeeding (self-reported),

• State diagnosis of any medical condition (angina/heart disease) precluding use of nicotine patch or gum, or by self-report in screening questionnaire

• Reporting using NRTs or e-cigarettes or within the last 30 days

• Have untreated/are undergoing current treatment for psychiatric illness or cognitive impairment at time of initial screening as determined by the subjects' primary care doctor or a licensed study team member in screening

• Report a history of severe or untreated cardiopulmonary disease such as asthma or emphysema.